Katherine Keever & Bardia Askari. (2024). Exacerbation of atherosclerosis, hyperlipidemia and inflammation by MK886, an inhibitor of leukotriene biosynthesis, in obese and diabetic mice. Elsevier.
Chicago Style (17th ed.) CitationKatherine Keever and Bardia Askari. Exacerbation of Atherosclerosis, Hyperlipidemia and Inflammation by MK886, an Inhibitor of Leukotriene Biosynthesis, in Obese and Diabetic Mice. Elsevier, 2024.
MLA (9th ed.) CitationKatherine Keever and Bardia Askari. Exacerbation of Atherosclerosis, Hyperlipidemia and Inflammation by MK886, an Inhibitor of Leukotriene Biosynthesis, in Obese and Diabetic Mice. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.